1.
Lik Sprava
; (1-2): 167-9, 2015.
Artículo
en Ucraniano
| MEDLINE
| ID: mdl-26118067
RESUMEN
The results of the examination of patients with type I children,which was diagnosed with celiac disease and pancreatic exocrine insufficiency. To correct the PEN used pancreatin preparations and studied its effectiveness.
Asunto(s)
Enfermedad Celíaca/tratamiento farmacológico , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Insuficiencia Pancreática Exocrina/tratamiento farmacológico , Fármacos Gastrointestinales/uso terapéutico , Pancreatina/uso terapéutico , Adolescente , Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/enzimología , Enfermedad Celíaca/fisiopatología , Niño , Preescolar , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/enzimología , Diabetes Mellitus Tipo 1/fisiopatología , Dieta Sin Gluten , Terapia de Reemplazo Enzimático , Insuficiencia Pancreática Exocrina/complicaciones , Insuficiencia Pancreática Exocrina/enzimología , Insuficiencia Pancreática Exocrina/fisiopatología , Heces/química , Femenino , Humanos , Masculino , Elastasa Pancreática/metabolismo , Resultado del Tratamiento
2.
Farmakol Toksikol
; 47(3): 87-90, 1984.
Artículo
en Ruso
| MEDLINE
| ID: mdl-6734813
RESUMEN
Antitoxic properties of cobamamide, a coenzymic form of vitamin B12, were studied in experimental toxic hepatitis induced by CCl4. The data obtained as a result of the assessment of the bromosulfalene test and activity of sorbitol dehydrogenase and alanine aminotransferase point to a demonstrable hepatoprotective action of cobamamide. Normalization of the indicators studied evidences that the drug intensifies the recovery processes occurring in the liver of rabbits with toxic hepatitis.
